These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 2901784

  • 21. [The role of Campylobacter pylori in gastroduodenal pathology].
    Sirigu F, Capeccioni S, Dessì A, Masia AM, Usai P.
    Recenti Prog Med; 1990 Mar; 81(3):142-5. PubMed ID: 2359867
    [Abstract] [Full Text] [Related]

  • 22. [Helicobacter pylori--an etiopathogenic factor of stomach and duodenal diseases among children].
    Czerwionka-Szaflarska M, Mierzwa G, Bała G.
    Pediatr Pol; 1995 Jul; 70(7):563-8. PubMed ID: 8649954
    [Abstract] [Full Text] [Related]

  • 23. Campylobacter pylori: a newly recognized infectious agent in the gastrointestinal tract.
    Yardley JH, Paull G.
    Am J Surg Pathol; 1988 Jul; 12 Suppl 1():89-99. PubMed ID: 3281485
    [Abstract] [Full Text] [Related]

  • 24. Drug therapy of peptic ulcer disease.
    Ching CK, Lam SK.
    Br J Hosp Med; 1988 Jul; 54(2-3):101-6. PubMed ID: 7551483
    [Abstract] [Full Text] [Related]

  • 25. [Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study].
    Bayerdörffer E, Pirlet T, Sommer A, Kasper G, Ottenjann R.
    Z Gastroenterol; 1988 Mar; 26(3):155-9. PubMed ID: 2900584
    [Abstract] [Full Text] [Related]

  • 26. [Chronic gastroduodenitis in children and Campylobacter pylori].
    Sklianskaia OA, Garkusha MB, Ufimtseva AG, Daurova NV, Chumakov AM, Sekamova SM, Zhukhovitskiĭ VG.
    Arkh Patol; 1990 Mar; 52(10):49-53. PubMed ID: 2281975
    [Abstract] [Full Text] [Related]

  • 27. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP, McKenna D, Humphreys H, Bourke S, Keane CT, Sweeney E, O'Morain C.
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [Abstract] [Full Text] [Related]

  • 28. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

  • 29. [Campylobacter pylori colonization and gastroduodenal pathology].
    Gullini S, Basso O, Boccia S, Macario F, Cantarini D, Ghinelli F.
    Minerva Med; 1988 Nov; 79(11):957-60. PubMed ID: 3200472
    [Abstract] [Full Text] [Related]

  • 30. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W.
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [Abstract] [Full Text] [Related]

  • 31. Biochemical changes induced by Campylobacter pylori in the gastric juice.
    Andreica V, Suciu A, Dumitraşcu D, Drăghici A, Pascu O, Suciu M, Ban A.
    Med Interne; 1990 Sep; 28(2):145-52. PubMed ID: 2270423
    [Abstract] [Full Text] [Related]

  • 32. [The role of Campylobacter pyloridis in the etiology and pathogenesis of peptic ulcer].
    Loginov AS, Lorie NIu, Il'chenko AA, Radbil' OS.
    Ter Arkh; 1988 Sep; 60(11):141-4. PubMed ID: 3070803
    [No Abstract] [Full Text] [Related]

  • 33. [Characteristics of the endoscopic diagnosis of peptic ulcer and chronic gastritis associated with Campylobacter pylori].
    Grigor'ev PIa, Agrba VZ, Isakov VA, Stepanov AV.
    Ter Arkh; 1989 Sep; 61(11):65-9. PubMed ID: 2699098
    [No Abstract] [Full Text] [Related]

  • 34. Campylobacter pylori in Saudi patients undergoing upper gastrointestinal endoscopy: prevalence and effect of conventional therapy.
    al-Freihi HM, al-Qurain A, al-Gindan Y, Ibrahim EM, Satti MB, Twum-Danso K, al-Idrissi HY, al-Ghassab G, al-Hamdan A.
    Hepatogastroenterology; 1989 Dec; 36(6):516-8. PubMed ID: 2613174
    [Abstract] [Full Text] [Related]

  • 35. Campylobacter pylori. The organism and its clinical relevance.
    Graham DY, Evans DG, Evans DJ.
    J Clin Gastroenterol; 1989 Dec; 11 Suppl 1():S43-8. PubMed ID: 2809138
    [Abstract] [Full Text] [Related]

  • 36. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
    Lazzaroni M, Bianchi Porro G.
    Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
    Popiela T, Kulig J, Karcz D, Tabor J, Torres J, Márquez M, Fillat O, Herrero E, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):573-7. PubMed ID: 9205768
    [Abstract] [Full Text] [Related]

  • 38. Cytoprotective agents and C. pylori associated acid peptic diseases.
    Andersen LP.
    Scand J Gastroenterol Suppl; 1988 Apr; 142():110-3. PubMed ID: 2901785
    [No Abstract] [Full Text] [Related]

  • 39. [Occurrence of Campylobacter pylori in patients with gastritis and peptic ulcer].
    Carneiro Leão G, Magalhães Filho M, Galvão LP, Machado RC, Padovan IP, Jucá NT, Lira VM, Magalhães M.
    Arq Gastroenterol; 1988 Apr; 25(1):23-8. PubMed ID: 3223826
    [Abstract] [Full Text] [Related]

  • 40. Ranitidine: a pilot study in Japan.
    Takemoto T, Okazaki Y, Okita K, Namiki M, Ishikawa M, Oshiba S, Kurokawa K.
    Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.